LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | WZ-4-145 | 0.37 | uM | LJP6 | 72 | hr | 1389 | 3794 | 5667 | 0.6694 | 0.5621 |
MCF7 | XMD16-144 | 0.37 | uM | LJP5 | 72 | hr | 1389 | 1804 | 5667 | 0.3183 | 0.0970 |
MCF7 | Brivanib | 0.37 | uM | LJP5 | 72 | hr | 1389 | 5637 | 5667 | 0.9946 | 0.9929 |
MCF7 | Buparlisib | 0.37 | uM | LJP5 | 72 | hr | 1389 | 2134 | 5667 | 0.3765 | 0.1741 |
MCF7 | BX-912 | 0.37 | uM | LJP5 | 72 | hr | 1389 | 5266 | 5667 | 0.9291 | 0.9061 |
MCF7 | Canertinib | 0.37 | uM | LJP6 | 72 | hr | 1389 | 4622 | 5667 | 0.8156 | 0.7557 |
MCF7 | Celastrol | 0.37 | uM | LJP6 | 72 | hr | 1389 | 3634 | 5667 | 0.6412 | 0.5247 |
MCF7 | CGP60474 | 0.37 | uM | LJP5 | 72 | hr | 1389 | 465 | 5667 | 0.0820 | -0.2160 |
MCF7 | CGP60474 | 0.37 | uM | LJP6 | 72 | hr | 1389 | 618 | 5667 | 0.1091 | -0.1801 |
MCF7 | CHIR-99021 | 0.37 | uM | LJP6 | 72 | hr | 1389 | 4034 | 5667 | 0.7118 | 0.6183 |
MCF7 | CP724714 | 0.37 | uM | LJP5 | 72 | hr | 1389 | 4622 | 5667 | 0.8156 | 0.7557 |
MCF7 | CP466722 | 0.37 | uM | LJP5 | 72 | hr | 1389 | 5956 | 5667 | 1.0509 | 1.0674 |
MCF7 | Crizotinib | 0.37 | uM | LJP5 | 72 | hr | 1389 | 4205 | 5667 | 0.7420 | 0.6582 |
MCF7 | Momelotinib | 0.37 | uM | LJP5 | 72 | hr | 1389 | 5393 | 5667 | 0.9516 | 0.9359 |
MCF7 | Dasatinib | 0.37 | uM | LJP5 | 72 | hr | 1389 | 1080 | 5667 | 0.1906 | -0.0722 |
MCF7 | Dasatinib | 0.37 | uM | LJP6 | 72 | hr | 1389 | 1028 | 5667 | 0.1814 | -0.0844 |
MCF7 | Dovitinib | 0.37 | uM | LJP5 | 72 | hr | 1389 | 4890 | 5667 | 0.8628 | 0.8183 |
MCF7 | Enzastaurin | 0.37 | uM | LJP5 | 72 | hr | 1389 | 6125 | 5667 | 1.0806 | 1.1068 |
MCF7 | Erlotinib | 0.37 | uM | LJP5 | 72 | hr | 1389 | 6206 | 5667 | 1.0949 | 1.1258 |
MCF7 | Foretinib | 0.37 | uM | LJP5 | 72 | hr | 1389 | 1881 | 5667 | 0.3320 | 0.1151 |
MCF7 | R406 | 0.37 | uM | LJP6 | 72 | hr | 1389 | 5010 | 5667 | 0.8840 | 0.8464 |
MCF7 | Pictilisib | 0.37 | uM | LJP6 | 72 | hr | 1389 | 1601 | 5667 | 0.2825 | 0.0496 |
MCF7 | Gefitinib | 0.37 | uM | LJP6 | 72 | hr | 1389 | 5783 | 5667 | 1.0203 | 1.0269 |
MCF7 | Geldanamycin | 0.37 | uM | LJP5 | 72 | hr | 1389 | 1509 | 5667 | 0.2662 | 0.0280 |
MCF7 | Geldanamycin | 0.37 | uM | LJP6 | 72 | hr | 1389 | 1401 | 5667 | 0.2472 | 0.0028 |